- 商品介绍
- 规格参数
- 包装参数
产品介绍
Product Description
Application
DOTMA is suitable for use in the synthesis of cationic microbubble.
Biochem/physiol Actions
DOTMA is a cationic lipid used as a non-viral vector for gene therapy. It exhibits effective in vitro and in vivo gene transfection. DOTMA induces a positive charge on the liposomes and thus promotes efficient liposome - cell membrane interaction.PMID 23591808
Packaging
5 mL Clear Glass Sealed Ampule (890898C-200mg)
5 mL Clear Glass Sealed Ampule (890898C-25mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
技术参数
Specifications
| assay | >99% (TLC) |
| form | liquid |
| packaging | pkg of 1 × 2.5 mL (890898C-25mg),pkg of 2 × 4 mL (890898C-200mg) |
| manufacturer/tradename | Avanti Research™ - A Croda Brand |
| concentration | 10 mg/mL (890898C-25mg),25 mg/mL (890898C-200mg) |
| web metadata keyword.default | 104872-42-6 DOTMA for liposome synthesis,Avanti DOTMA,DOTMA cationic lipid for advanced drug delivery,DOTMA cationic lipid with positive charge,DOTMA cationic lipid,DOTMA cationic liposome transfection reagent,DOTMA for cationic microbubble synthesis,DOTMA for laboratory research,DOTMA gene therapy vector,DOTMA lipid for in vivo gene transfection,DOTMA lipid-based vector for gene therapy,DOTMA liposome formulation,DOTMA non-viral gene therapy reagent,DOTMA pharmaceutical grade for gene delivery |
| application(s) | advanced drug delivery |
| lipid type | transfection cationic lipids |
| shipped in | dry ice |
| storage temp. | −20°C |
| SMILES string | [H]C(C[N+](C)(C)C)(OCCCCCCCC/C=C\CCCCCCCC)COCCCCCCCC/C=C\CCCCCCCC.[Cl-] |
| InChI | 1S/C42H84NO2.ClH/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-44-41-42(40-43(3,4)5)45-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2;/h20-23,42H,6-19,24-41H2,1-5H3;1H/q+1;/p-1/b22-20-,23-21-; |
| InChI key | LDGWQMRUWMSZIU-LQDDAWAPSA-M |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
猜你喜欢




微信小程序
7X24小时在线咨询